NCT03377049View on ClinicalTrials.gov

Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 28, 2019

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Subarachnoid Hemorrhage, AneurysmalVasospasm, Cerebral
Interventions
DRUG

Acetazolamide

1 g acetazolamide through a peripheral IV line

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT03377049 - Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm | Biotech Hunter | Biotech Hunter